Related Experiment Video
Updated: Feb 25, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Predictors of Inappropriate Use of Diagnostic Tests and Management of Bronchiolitis
Lorena Sarmiento1, Gladys E Rojas-Soto2, Carlos E Rodríguez-Martínez3,4
1Department of Pediatrics, Clinica Universitaria Colombia, Fundacion Universitaria Sanitas, Bogota, Colombia.
Insights
Inappropriate diagnostic tests and treatment for bronchiolitis are common in hospitalized infants. Infants with atopic dermatitis, longer hospital stays, and more siblings face higher risks.
Area of Science:
- Pediatrics
- Infectious Diseases
- Clinical Medicine
Background:
- Bronchiolitis is a common respiratory infection in infants, often leading to hospitalization.
- Inappropriate diagnostic testing and management can increase healthcare costs and negatively impact patient outcomes.
- Identifying predictors of inappropriate care is crucial for improving bronchiolitis management.
Purpose of the Study:
- To identify independent predictors of inappropriate diagnostic test use and management in hospitalized infants with bronchiolitis.
- To establish a composite outcome score to quantify the extent of inappropriate care.
Main Methods:
- An analytical cross-sectional study design was employed.
- Data were collected from 303 hospitalized infants diagnosed with bronchiolitis.
- A composite outcome score was defined to measure inappropriate diagnostic tests and management.
Main Results:
- A high prevalence of inappropriate care was observed, affecting 71.3% of the study population.
- Independent predictors identified include atopic dermatitis (OR 5.30), longer hospital stay (OR 1.48), and a higher number of siblings (OR 1.92).
- Statistical significance was established for all identified predictors (p < 0.05).
Conclusions:
- Inappropriate diagnostic tests and treatment for bronchiolitis are highly prevalent in hospitalized infants.
- Infants with atopic dermatitis, extended hospital stays, and more siblings are at significantly increased risk.
- These findings highlight the need for targeted interventions to optimize bronchiolitis care and reduce unnecessary interventions.
Background:
The aim of the present study was to determine predictors of inappropriate use of diagnostic tests and management of bronchiolitis in a population of hospitalized infants.
Methods:
In an analytical cross-sectional study, we determined independent predictors of the inappropriate use of diagnostic tests and management of bronchiolitis in a population of hospitalized infants. We defined a composite outcome score as the main outcome variable.
Results:
Of the 303 included patients, 216 (71.3%) experienced an inappropriate use of diagnostic tests and treatment of bronchiolitis. After controlling for potential confounders, it was found that atopic dermatitis (OR 5.30; CI 95% 1.14-24.79; p = 0.034), length of hospital stay (OR 1.48; CI 95% 1.08-2.03; p = 0.015), and the number of siblings (OR 1.92; CI 95% 1.13-3.26; p = 0.015) were independent predictors of an inappropriate use of diagnostic tests and treatment of the disease.
Conclusions:
Inappropriate use of diagnostic tests and treatment of bronchiolitis was a highly prevalent outcome in our population of study. Participants with atopic dermatitis, a longer hospital stay, and a greater number of siblings were at increased risk for inappropriate use of diagnostic tests and management of the disease.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
COPD: Management Using Bronchodilators and Corticosteroids
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Pneumonia III: Complications and Assessment
Asthma-IV: Nursing Management
First, in...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
